Back to Oncology
Oncologyvclive_2014Evidence-Based

LENT Prognostic Score for Malignant Pleural Effusion

Predicts survival in patients with malignant pleural effusion using clinical and laboratory parameters to help inform treatment decisions and prognosis discussions

Clinical Input Parameters

U/L
Range: 0 — 10000 U/L
Range: 0 — 100
Clinical Assessment
Awaiting Parameters
lent score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The LENT Prognostic Score for Malignant Pleural Effusion is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within oncology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

LENT Score = LDH points + ECOG points + Neutrophil-lymphocyte ratio points + Tumor type points

Clinical Pearls & Practice Notes

  • LENT stands for: LDH, ECOG performance status, Neutrophil-to-lymphocyte ratio, Tumor type
  • Developed specifically for patients with malignant pleural effusion
  • Helps identify patients who might benefit from less invasive interventions
  • Useful for clinical trial stratification and research purposes
  • Score ranges from 0 to 7 points total
  • Not meant to replace clinical judgment in treatment decisions
  • Should be used in conjunction with other clinical factors and patient preferences
  • Particularly helpful for discussions about prognosis and goals of care
  • ECOG 0: Fully active, able to carry on all pre-disease activities without restriction
  • ECOG 1: Restricted in physically strenuous activity but ambulatory and able to carry out light work
  • ECOG 2: Ambulatory and capable of all self-care but unable to carry out any work activities; up and about >50% of waking hours
  • ECOG 3: Capable of only limited self-care; confined to bed or chair >50% of waking hours
  • ECOG 4: Completely disabled; cannot carry on any self-care; totally confined to bed or chair
  • Pleural fluid LDH ≥1,500 U/L suggests more aggressive disease
  • Neutrophil-to-lymphocyte ratio ≥9 indicates systemic inflammatory response
  • Tumor type reflects different biological behaviors and treatment responses

Evidence & Literature Citations

  1. Clive AO, Kahan BC, Hopwood BE, Bhatnagar R, Morley AJ, Zahan-Evans N, et al. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax. 2014 Dec;69(12):1098-104.
  2. Psallidas I, Kanellakis NI, Gerry S, Theza A, Saba T, Tsim S, et al. Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis. Lancet Oncol. 2018 Jul;19(7):930-939.
  3. Porcel JM. Malignant pleural effusion. Current opinion in Pulmonary Medicine. 2016 Jul;22(4):356-61.

Score Interpretation Ranges

Low Risk0 – 1 pts

Low risk of mortality

Moderate Risk2 – 4 pts

Moderate risk of mortality

High Risk5 – 7 pts

High risk of mortality

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.